• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500074 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2025-04-03 Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2400138 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) New Drug Application 2024-12-14 Zhejiang HUAHAI Biopharmaceuticals Co Ltd view
CYSB2400326 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2024-12-14 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CYSB2400263 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2024-09-28 SinoCelltech Ltd view
JYSZ2400050 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-09-04 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
CYSB2400155 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-06-18 Hisun Biopharmaceutical Co Ltd view
CYSB2400125 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2024-05-22 SinoCelltech Ltd view
JYSZ2400024 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-05-14 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
JYSZ2400023 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-05-14 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
CYSB2400051 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400052 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400049 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400050 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400023 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-01-23 Hisun Biopharmaceutical Co Ltd view
CXSS2300100 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) New Drug Application 2023-12-19 Wuhan Institute of Biological Products Co Ltd view
JYSB2300141 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2023-08-18 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2300140 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2023-07-22 Innovent Biologics (Suzhou) Co Ltd view
CYSB2300080 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2023-04-11 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300050 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2023-02-23 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CYSB2300024 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2023-01-31 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view